- About Us
- Nano-Social Network
- Nano Consulting
- My Account
BioForce Nanosciences Holdings, Inc. (OTC Bulletin Board: BFNH.OB), today comments on making the
"Class of 2006" list of nanotech stocks to watch. Found on Forbes.com, the list is an update of a scorecard the Forbes/Wolfe Nanotech Report developed some years ago. It names BioForce among 20 nano-related companies to keep an eye on, while cautioning that inclusion isn't a recommendation.
"We've believed all along that our surface patterning technology is new
and exciting," notes BioForce's Kerry Frey, chief operating officer. "The
variety of research being conducted utilizing nanotechnology as the
standard has exploded. Our niche in the life sciences discipline is a
strategic move as biosensors and nanosensors move from academic R&D into
commercial product development." BioForce only entered public trading in
March 2006 but has been in business since 1994. The bulk of BioForce's
business falls under its wholly owned subsidiary, BioForce Nanosciences,
Inc. Their flagship product, the Nano eNabler(TM) system, is a benchtop
molecular printer that places tiny domains of biological materials onto
surfaces with nanometer spatial precision.
The Forbes/Wolfe report states that 2006 wasn't a banner year for
nanotech stocks, but assures that for the patient investor, rewards are on
the horizon for nanotech and nano-related stocks. The life sciences
discipline is receiving positive reports as well. For example, Ernst &
Young, LLP reported in 2006 that the American biotechnology industry has
surpassed pharmaceutical companies for the third straight year as the
primary source of new medicines, and biotech revenue jumped nearly 16
percent to a record $50.7 billion in 2005.
BioForce Nanosciences Holdings, Inc. (OTC Bulletin Board: BFNH.OB) is
the parent company of BioForce Nanosciences, Inc. BioForce Nanosciences is
a unique company entering into commercialization with over a decade of
research and accomplishment in the field of bionanotechnology. BioForce has
demonstrated the ability to take a product from concept to commercial sale.
For more information, visit http://www.bioforcenano.com .
This news release contains forward-looking information that may be
affected by certain risks and uncertainties, including those risks and
uncertainties described in the Company's most recent filings with the
Securities and Exchange Commission. The Company's actual results could
differ materially from such forward-looking statements. We assume no duty
to update these statements at any future date.
For more information, please click here
BioForce Nanosciences, Inc.
1615 Golden Aspen Drive, Suite 101
Ames, IA 50010 USA
Phone: 515.233.8333 ext. 101
Copyright © BioForce Nanosciences Holdings, Inc.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Better living through pressure: Functional nanomaterials made easy April 19th, 2017
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016